6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
Just now	Check Point Infinity Platform for Government Achieves GovRAMP Authorization
Just now	red violet to Present at the 21st Annual Needham Technology, Media & Consumer Conference
Just now	CytomX Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
Just now	Immutep Receives Nasdaq Notice of Bid Price Deficiency
Just now	Harmonic to Unveil Game-Changing Innovations at Fiber Connect 2026

About

Enliven Therapeutics Inc. (NASDAQ:ELVN) — investor relations, events, news, and company updates on 6ix.

Latest News

Enliven Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update

Enliven Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference

Enliven Reports Positive Initial Phase 1b Data for ELVN-001 in CML and Outlines 2026 Clinical Milestones

Enliven Therapeutics Bolsters Board to Prepare for Next Phase of Development

Enliven Therapeutics Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

Financials

Revenue

$0

Market Cap

$2.33 B

EPS

-1.83

Community Chat

Ask AI